Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting
Value Health
.
2014 Nov;17(7):A615.
doi: 10.1016/j.jval.2014.08.2164.
Epub 2014 Oct 26.
Authors
C M Gallagher
1
,
K More
2
,
A S Masaquel
3
,
T Kamath
3
,
A Guerin
4
,
R Ionescu-Ittu
4
,
M Gauthier-Loiselle
4
,
R Nitulescu
4
,
N Sicignano
5
,
B Barnett
3
,
E Q Wu
6
Affiliations
1
Walter Reed National Military Medical Center, Bethesda, MD, USA.
2
Naval Medical Center Portsmouth, Portsmouth, VA, USA.
3
Genentech, South San Francisco, CA, USA.
4
Analysis Group, Inc., Montréal, QC, Canada.
5
Health ResearchTx, Trevose, VA, USA.
6
Analysis Group, Inc., Boston, MA, USA.
PMID:
27202155
DOI:
10.1016/j.jval.2014.08.2164
No abstract available